Richard D. Bulbrook

Richard D. Bulbrook's AcademicInfluence.com Rankings

Richard D. Bulbrook

Philosophy

#9325

World Rank

#12865

Historical Rank

Ontology

#119

World Rank

#133

Historical Rank

Logic

#6309

World Rank

#7818

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Richard D. Bulbrook Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard D. Bulbrook's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (1997) (2362)
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies (1996) (1205)
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer (1982) (460)
Bilateral primary breast cancer: A prospective study of disease incidence (1984) (236)
Relation between urinary androgen and corticoid excretion and subsequent breast cancer. (1971) (229)
Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. (1984) (205)
An additional purification step for a method for estimating oestriol, oestrone and oestradiol-17 beta in human urine. (1957) (182)
TEN YEARS' EXPERIENCE OF STEROID ASSAYS IN THE MANAGEMENT OF BREAST CANCER (1968) (172)
Breast cancer and hormonal contraceptives: further results (1996) (158)
Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. (1960) (132)
Aldosterone secretion and metabolism in normal men and women and in pregnancy. (1959) (116)
THE PREVENTION OF BREAST CANCER (1986) (115)
An evaluation of a chemical method for the estimation of oestriol, oestrone and oestradiol-17 beta in human urine. (1957) (115)
Hormones and breast cancer. (1992) (113)
Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey. (1967) (108)
Serum ferritin concentration in early breast cancer. (1976) (102)
Abnormal excretion of urinary steroids by women with early breast cancer. (1962) (102)
A comparison between the urinary steroid excretion of normal women and women with advanced breast cancer. (1962) (84)
The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. (1988) (74)
Relationship of blood prolactin levels and the risk of subsequent breast cancer. (1992) (74)
UICC multidisciplinary project on breast cancer: The epidemiology, aetiology and prevention of breast cancer (1986) (73)
CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER (1983) (72)
Plasma prolactin levels and breast cancer: Relation to parity, weight and height, and age at first birth (1981) (70)
The metabolic clearance rates of dehydroepiandrosterone, testosterone and their sulphate esters in man, rat and rabbit. (1967) (67)
CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCER (1984) (67)
Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. (1987) (67)
Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. (1990) (65)
A prospective study of urinary oestrogen excretion and breast cancer risk. (1996) (65)
Cigarette smoking and steroid hormones in women (1991) (64)
The epidemiology and etiology of breast cancer. (1980) (61)
Persistence of Urinary Oestrogen Excretion After Oophorectomy and Adrenalectomy (1957) (60)
Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol. (1973) (56)
Distribution of 17 β-Estradiol in the Sera of Normal British and Japanese Women (1983) (54)
The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. (1987) (53)
Serum prolactin levels in women with breast cancer and their relationship to survival. (1986) (53)
Ten years' experience of sterioid assays in the management of breast cancer. A review. (1968) (51)
THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY. (1964) (49)
Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey (2000) (47)
Accumulation of tritiated oestradiol by human breast tissue. (1967) (45)
Endocrine status in normal British, Japanese and Hawaiian-Japanese women. (1978) (45)
A prospective study of plasma prolactin levels and subsequent risk of breast cancer (1981) (44)
Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer. (1978) (44)
The relation between radiographic features and determinants of risk of breast cancer. (1980) (43)
A prospective study of the relationship between serum vitamins A and E and risk of breast cancer. (1988) (41)
A prospective study of mammographic parenchymal patterns and risk of breast cancer. (1986) (41)
Urinary and plasma androgens in benign breast disease. Possible relation to breast cancer. (1973) (39)
Plasma prolactin and its relationship to risk factors in human breast cancer (1976) (39)
The urinary excretion of 11-deoxy-17-oxosteroids and 17-hydroxycorticosteroids by normal Japanese and British women. (1967) (38)
Studies on the sulphate esters of dehydroepiandrosterone and androsterone in the blood of women with breast cancer. (1974) (38)
Oophorectomy in Breast Cancer (1958) (38)
SCREENING, DETECTION, AND DIAGNOSIS OF BREAST CANCER (1982) (37)
Breast cancer in Britain and Japan: plasma oestradiol-17beta, oestrone and progesterone,and their urinary metabolites in normal British and Japanese women. (1976) (36)
Determination of solvolysed sulphate esters of dehydroepiandrosterone and androsterone in human peripheral plasma by gas-liquid chromatography. (1968) (34)
Commentaries on research in breast disease (1983) (33)
Sinus histiocytosis in British and Japanese patients with breast cancer. (1974) (33)
Cigarette smoking and prolactin in women. (1986) (32)
OVULATORY FAILURE IN A NORMAL POPULATION AND IN PATIENTS WITH BREAST CANCER (1974) (32)
Adrenalectomy in Breast Cancer (1958) (32)
Steroid sulphatase, arylsulphatase and β-glucuronidase in marine invertebrates (1960) (32)
Selenium in human mammary carcinogenesis: a case-cohort study. (1991) (32)
Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women. (1976) (32)
The relation between radiological patterns of the breast and body weight and height. (1982) (31)
Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer. (1984) (31)
Serum progesterone concentration during the luteal phase in women with benign breast disease. (1984) (31)
Hormone assays in human breast cancer. (1965) (30)
Serum prolactin levels and their relationship to survival in women with operable breast cancer. (1995) (29)
The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom) (1993) (28)
Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast. (1979) (28)
Copper in human mammary carcinogenesis: a case-cohort study. (1993) (28)
Steroid sulphatase, arylsulphatase and β-glucuronidase in the mollusca (1960) (28)
The determination of small quantities of urinary oestrone, oestradiol-17 beta and oestriol using Ittrich's extraction method. (1961) (28)
Binding of the sulphate esters of dehydroepiandrosterone, testosterone, 17-acetoxypregnenolone and pregnenolone in the plasma of man, rabbit and rat. (1967) (27)
Plasma and urinary androgens in women with varying degrees of risk of breast cancer. (1979) (25)
Thyroid function in early breast cancer. (1983) (25)
Urinary and plasma androgens and their relation to familial risk of breast cancer. (1975) (25)
Influence of reproductne history on age at diagnosis of breast cancer and prognosis (1985) (24)
URINARY STEROID ESTIMATIONS IN THE PREDICTION OF RESPONSE TO ADRENALECTOMY OR HYPOPHYSECTOMY. (1964) (23)
Hormones are ambiguous risk factors for breast cancer. (1989) (23)
PLASMA 17-HYDROXYCORTICOSTEROIDS AND 17-OXOSTEROIDS IN PATIENTS WITH BREAST CANCER AND IN NORMAL WOMEN. (1965) (23)
Adrenal function in breast cancer: production and metabolic clearance rate of cortisol in patients with early or advanced breast cancer and in normal women. (1968) (22)
Plasma oestradiol and progesterone in benign breast disease. (1973) (21)
Adrenal function in breast cancer: biogenesis of androgens and cortisol by the human adrenal gland in vivo. (1970) (21)
Hypophysectomy in Breast Cancer (1958) (20)
Urinary steroids in the prediction of response to adrenalectomy or hypophysectomy. A second clinical trial. (1968) (20)
Endocrine studies in African males with nasopharyngeal cancer. (1966) (19)
The correlation between urinary oestrogen and vaginal cytology. (1957) (19)
Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids. (1959) (19)
Urinary androgen metabolites and recurrence rates in early breast cancer. (1982) (18)
The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. (1989) (18)
Long term adjuvant therapy for primary breast cancer (1996) (18)
Salivary oestradiol and progesterone levels in premenopausal women with breast cancer. (1986) (18)
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer. (1984) (18)
Metabolic clearance rates of pregnenolone, 17-acetoxypregnenolone and their sulphate esters in man and in rabbit. (1967) (17)
A RAPID METHOD FOR THE ESTIMATION OF TOTAL 11-DEOXY-17-OXOSTEROIDS IN URINE. (1964) (16)
Thyroid function and the incidence of breast cancer in Hawaiian, British and Japanese women (1986) (16)
Effect of Hypophysectomy on Urinary Oestrogen in Breast Cancer (1957) (16)
Identification of women at high risk of breast cancer. (1986) (15)
Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease. (1984) (15)
The possibility of predicting the response of patients with early breast cancer to subsequent endocrine ablation. (1965) (15)
Relationships between excretion of steroid hormones and tryptophan metabolites in patients with breast cancer. (1971) (15)
Abnormalites in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease (1978) (15)
Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer. (1966) (15)
The binding of steroids to plasma proteins in normal women and women with breast cancer. (1969) (15)
Pituitary growth hormone and the glucose utilization of rat diaphragm. (1955) (14)
Plasma prolactin, thyroid-stimulating hormone, follicle-stimulating hormone and luteinizing hormone in normal British and Japanese women. (1976) (14)
A METHOD FOR THE SIMULTANEOUS DETERMINATION OF 17-OXOSTEROIDS AND 17-HYDROXYCORTICOSTEROIDS IN HUMAN PLASMA. (1964) (14)
Urinary androgen excretion and the etiology of breast cancer. (1972) (13)
Urinary steroid assays and response to endocrine ablation. (1967) (13)
The value of urinary steroid estimations in the prediction of response to adrenalectomy or hypophysectomy. (1965) (13)
Blood concentrations of estradiol and sex hormone-binding globulin in relation to age at menarche in premenopausal British and Japanese women (1991) (13)
Hormone studies in cases of testicular feminization (1965) (13)
Plasma androstenedione levels in women with breast cancer. (1977) (13)
In vivo steroidogenesis by the human adrenal gland. (1967) (12)
Some aspects of the measurement of cortisol production in patients with breast cancer. (1969) (12)
Serum prolactin, androgens, oestradiol and progesterone in adolescent girls with or without a family history of breast cancer. (1981) (12)
Breast parenchymal patterns in women with bilateral primary breast cancer. (1983) (12)
The distribution of estradiol in the sera of normal Caucasian, Chinese, Filipina, Hawaiian and Japanese women living in Hawaii. (1988) (12)
Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives. (1969) (11)
The epidemiology and function of sex hormone-binding globulin. (1988) (11)
The relationship between urinary androst-16-en-3alpha-ol and urinary 11-deoxy-17-oxosteroid excretion. (1963) (11)
Plasma-testosterone levels in Kenyan men in relation to cancer of the nasopharynx. (1966) (11)
HORMONE EXCRETION IN PROSTATIC CANCER (1959) (11)
Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study. (1988) (11)
Plasma FSH and LH in post-menopausal women with breast cancer. (1976) (10)
The uptake of tritiated steroids by human breast carcinoma. (1969) (10)
Tryptophan metabolism and recurrence rates of patients with breast cancer after mastectomy. (1975) (9)
The uptake of radioactivity by normal and neoplastic human breast tissues after administration of tritiated testosterone (1965) (9)
A rapid method for the estimation of urine 11-deoxy-17-oxosteroids and its use in the management of patients with breast cancer (1968) (9)
Transcortin in the plasma of patients with breast cancer. (1967) (9)
Tests of prediction (1974) (9)
Family history and bilateral primary breast cancer (2005) (9)
Possible relationship of plasma IgA, IgG and IgM to breast cancer in British and Japanese women. (1977) (9)
Hormone Excretion in Prostatic Cancer: An Attempt to Correlate Urinary Hormone Excretion and Clinical State (1959) (9)
Conjugated and unconjugated dehydroepiandrosterone, aetiocholanolone and androsterone in the peripheral plasma of patients with cancer of the breast, ovary, uterus or prostate. (1969) (9)
Oophorectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. (1958) (9)
Comparison of biological and chemical estimations of urinary oestrogens. I. Urine from normal men and women and a eunuch. (1957) (9)
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast (2005) (8)
Comparison of biological and chemical estimations of urinary oestrogens. II. Urine from patients with breast cancer maintained on cortisone after oophorectomy-adrenalectomy or hypophysectomy. (1960) (8)
Hormone Excretion in Precocious Puberty in Girls (1958) (8)
Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapy. (1982) (8)
Breast cancer risk is positively associated with height (1997) (8)
Sex Hormone‐Binding Globulin and the Natural History of Breast Cancer (1988) (8)
Adrenal function in breast cancer: the distribution of cortisol in patients with early or advanced breast cancer and in normal women. (1968) (7)
Adjuvant androgen treatment of operable breast cancer--a 20 year analysis. (1987) (7)
Concentrations of Sex-Hormone-Binding-Globulin (SHBG) in a population of normal women: Relationship to risk factors for breast cancer (1988) (7)
Comparison of pituitary function and clinical response after transphenoidal and transfrontal hypophysectomy for advanced breast cancer. (1976) (7)
Prognostic factors and tumour markers in early breast cancer; a commentary. (1983) (7)
Hormones in the aetiology and clinical course of breast cancer. (1972) (7)
Relation between endocrine function and survival of patients with breast cancer after hypophysectomy. (1979) (7)
The relation between sebum production and plasma 17-oxosteroid levels in normal women and in patients with breast cancer. (1972) (7)
A comparison of epidemiological characteristics in breast cancer patients and normal women in Great Britain and Japan: Results of a prospective study (1991) (7)
Tryptophan metabolism and recurrence rates after mastectomy in patients with breast cancer (1972) (7)
An apparent selective accumulation of testosterone by human breast tissue. (1963) (7)
Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. (1984) (7)
Oestrogens in the initiation and promotion of breast cancer (1989) (7)
Plasma-levels of the sulphate esters of dehydroepiandrosterone and androsterone in Kenyan men and their relation to cancer of the nasopharynx. (1968) (6)
The isolation of androsterone and aeticholanolone from the urine of oophorectomised-adrenalectomised women. (1960) (6)
Relation between plasma-cortisol, plasma-androgen-sulphates, and immune response in women with breast cancer. (1971) (6)
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast (2005) (6)
The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan. (1982) (5)
Adrenalectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. (1958) (5)
Pathology of primary tumors and axillary lymph nodes in British and Japanese women with breast cancer (2005) (5)
The persistence of oestrogen production after endocrine ablation. (1957) (5)
SIMULTANEOUS DETERMINATION OF 17-OXOSTEROIDS AND 17-HYDROXY-CORTICOSTEROIDS IN PLASMA FROM NORMAL WOMEN. (1964) (5)
Recurrence and survival rates in British and Japanese women with breast cancer (1991) (5)
Hypophysectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. (1958) (5)
Urinary II-Deoxy-17-oxosteroids in British and Japanese Women with Reference to the Incidence of Breast Cancer (1964) (5)
Steroids in Cancer (1963) (5)
SELECTION OF BREAST-CANCER PATIENTS FOR ADRENALECTOMY AND HYPOPHYSECTOMY (1960) (4)
A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women (1991) (4)
Sex hormone-binding globulin and recurrence after mastectomy. (1979) (4)
The plasma levels of dehydroepiandrosterone sulphate, androsterone sulphate, cortisol and transcortin in Chinese, Indian and Malay males. (1969) (4)
Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer (1988) (3)
Urinary steroid profiles in normal women and in patients with breast cancer in Britain and Japan: relation to thyroid function. (1977) (3)
Thymus and breast cancer--plasma androgens, thymic pathology, and peripheral lymphocytes in myasthenia gravis. (1977) (3)
Distribution of 17 beta-estradiol in the sera of normal British and Japanese women. (1983) (3)
Steroid hormones in lymph and blood from women with early breast cancer. (1991) (3)
A modification of a method for the determination of urinary pregnanetriol. (1960) (2)
Post-operative serum sialyltransferase levels and prognosis in breast cancer (2005) (2)
Some basic difficulties in attempting to predict response to therapy by endocrine assays. (1971) (2)
In-vitro steroidogenesis by an undifferentiated embryonal cell sarcoma of the ovary. (1969) (2)
Endocrine, genetic and viral factors in the etiology of breast cancer. (1972) (2)
The simultaneous determination of plasma 17-oxosteroids and 17-hydroxycorticosteroids in normal men. (1966) (2)
Urinary epidermal growth factor excretion and breast cancer risk. (1988) (2)
Steroid sulphatase, arylsulphatase and beta-glucuronidase in the Mollusca. (1960) (2)
The distribution of [1,2-3H]testosterone in the tissues of female rats. (1966) (2)
ACCUMULATION OF 3H-OESTRADIOL BY THE HUMAN BREAST TISSUE (1967) (2)
The length of pregnancy and the level of incorporation of [methyl-3H]thymidine into mouse mammary gland explants in culture. (1970) (2)
The Guernsey Trial. A prospective investigation of hormone patterns and subsequent breast cancer. (1968) (2)
Oestrogens and the etiology and clinical course of breast cancer. (1984) (1)
Comparison between uptake of radioactivity by normal and neoplastic human breast tissue after single injection and intravenous infusion of tritiated testosterone. (1966) (1)
Discriminants and breast cancer. (1969) (1)
The possibility of accurate prediction of recurrence rates after mastectomy. (1980) (1)
A retrospective view of androgen and corticoid metabolites in the aetiology and clinical course of breast cancer (1997) (1)
92134257 Relationship of blood prolactin levels and the risk of subsequent breast cancer (1992) (1)
TRANSCORTIN IN BREAST-CANCER PATIENTS (1967) (1)
Hormonal factors in the etiology and treatment of breast cancer. (1966) (1)
The effect of NADPH on steroidogenesis by the human adrenal gland in vivo. (1969) (1)
The relationship between delayed hypersensitivity responses and blood steroid and androgen levels in cancer patients. (1970) (1)
Tumour and patient variables as Indicators of Prognosis. The silent period (1986) (1)
ANDROGENS IN HUMAN BREAST CANCER. (1964) (1)
Endocrine aspects of breast and prostatic cancer: an overview. (1986) (1)
Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer (2005) (1)
Geographical variation in endocrine function and its relation to breast cancer incidence: Some general considerations (1991) (1)
Androgens (1964) (0)
The possibility of preventive hormone therapy in women with a high risk of breast cancer. (1970) (0)
Effects of pituitary growth hormone on glucose utilization by muscle. (1954) (0)
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. (1996) (0)
Endocrinological aspects of benign breast disease. (1992) (0)
Clinical Chemistry and Breast Cancer (1976) (0)
Al Segaloff: Recollections from England (1985) (0)
Risk factors in breast cancer. (1977) (0)
The relation between radiographic features and (1980) (0)
46 Biologically available oestradiol and risk of breast cancer (1983) (0)
Adjuvant treatment with tamoxifen. Care is necessary. (1996) (0)
HORMONE EXCRETION IN PRECOCIOUS PUBERTY IN GIRLS and 25-0 (2007) (0)
Hormone studies in the diagnosis of early breast cancer. (1968) (0)
Epidemiological Clues in Breast Cancer (1972) (0)
STEROID SYNTHESIS IN HUMAN ADRENAL GLANDS IN VIVO (1969) (0)
New format for figures (1998) (0)
1. Endocrine determinants of risk of breast cancer (1979) (0)
Problems in hormonal therapy for advanced breast cancer. (1977) (0)
1 Levels of foetal steroid binding protein are reduced in a female population at increased risk of breast cancer (1985) (0)
Hormone studies in the selection of patients with advanced breast cancer for adrenalectomy or hypophysectomy. (1968) (0)
A METHOD FOR DETERMINING THE RADIOCHEMICAL PURITY OF STEROIDS. (1968) (0)
Foetal steroid binding protein in British and Japanese women. (1987) (0)
Plasma steroids and nasopharyngeal carcinoma. (1974) (0)

This paper list is powered by the following services:

Richard D. Bulbrook's Academic­Influence.com Rankings

Why Is Richard D. Bulbrook Influential?

Richard D. Bulbrook's Published Works

Published Works

Richard D. Bulbrook's AcademicInfluence.com Rankings